CXCL8 and rheumatoid arthritis: Moreover, this study is the first to report site-specific cleavage of CXCL8 in synovial fluids from patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA), thereby opening a window of oppurtunitiy for identification of disease biomarkers and potential therapeutic targets.